SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $15.63 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.